3D Printed Personalized Extendable Prosthesis

3D Printed Personalized Extendable Prosthesis Replacement for Limb Preservation in Children With Osteosarcoma: a Preliminary Study

NCT05794594•Yuxi Su

View on ClinicalTrials.gov

Summary

The goal of this type of observational study is to investigate the preliminary effect of 3D printed personalized extendable prosthesis replacement on limb salvage in children with osteosarcoma. The main question it aims to answer is: Is 3D printed personalized extendable prosthesis replacement has a good outcome in limb salvage pediatric osteosarcoma？

Detailed Description

Osteosarcoma is one of the most common primary malignant bone tumors in children and adolescents. In this study, the investigators try to investigate the preliminary effect of 3D printed personalized extendable prosthesis replacement on limb salvage in children with osteosarcoma.

Eligibility

Age

6 - 18 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•tumors of the extremities, with moderate soft-tissue invasion
•the neurovascular bundle is not invaded, and the tumor can be excised totally
•no metastatic lesions or metastases can be cured

Exclusion Criteria

•recurrent tumors
•poorly differentiated tumors
•poor soft-tissue conditions
•neurovascular invasion around tumors
•ineffective chemotherapy with metastasis

Locations (1)

Children's Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China

Key Dates

Start Date

October 1, 2015

Primary Completion Date

January 1, 2023

Completion Date

March 1, 2023

Last Updated

April 3, 2023

Enrollment

ACTUAL participants

Conditions

Osteosarcoma in Children

Interventions

3D printed personalized extendable prosthesis

DEVICE

Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma

NCT07144254

Osteosarcoma RecurrentOsteosarcoma in Children+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 3, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions